Orchestra BioMed Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Orchestra BioMed Holdings's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 22% to $2,760,000. Profit margin reached -1780%. Total operating expenses were $54,080,000.

Profit Margin

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO): Profit margin
2020 5.70M -21.35M -374.45%
2021 -782K -23.01M 2942.97%
2022 3.53M -33.60M -951.26%
2023 2.76M -49.12M -1779.71%

OBIO Income Statement (2020 – 2023)

2023 2022 2021 2020
Revenue
Revenue
2.76M3.53M-782K5.70M
Cost of revenue
186K322K199K145K
Gross profit
2.57M3.21M-981K5.55M
Operating exp.
Research and development
33.82M21.94M12.89M13.47M
Selling and marketing
0000
Total operating expenses
54.08M35.86M20.81M24.31M
Operating income
-51.50M-32.65M-21.79M-18.75M
Other income (expenses), net
2.38M-951K-288K-2.60M
Income before tax
-49.12M-33.60M-23.01M-21.35M
Income tax expense
0-221.99K927K2.60M
Net income
-49.12M-33.60M-23.01M-21.35M
Earnings per share
Basic EPS
-1.48-2.24-1.13-1.04
Diluted EPS
-1.48-2.24-1.13-1.04
Data source